Hairong Zhang

2 ta ish

Yangtze River Pharmaceutical Group (China)

1. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity

   Feng Yang, Aimei Li, Han Liu +1

   MaqolaOAOchiq kirish20182 iqtibos

   ABIABI:AkademIndex/2026.other.091424

2. Study on optimization and combination strategy of multiple daily runoff prediction models coupled with physical mechanism and LSTM

   Jun Guo, Yi Liu, Qiang Zou +3

   MaqolaOAOchiq kirish20232 iqtibos

   ABIABI:AkademIndex/2026.other.092355